Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,160 | -12,019 | -9,642 | -6,848 | -3,351 |
| Depreciation Amortization | 73 | 351 | 280 | 191 | 97 |
| Accounts payable and accrued liabilities | -186 | 37 | 316 | 446 | -61 |
| Other Working Capital | -611 | 427 | 1,787 | 2,419 | 2,720 |
| Other Operating Activity | 340 | 878 | 414 | 82 | 372 |
| Operating Cash Flow | $-2,545 | $-10,326 | $-6,846 | $-3,710 | $-222 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -92 | -70 | -12 | -6 |
| Investing Cash Flow | $-1 | $-92 | $-70 | $-12 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 13,286 | 12,607 | 12,099 | N/A |
| Common Stock Repurchased | N/A | -5 | N/A | N/A | N/A |
| Other Financing Activity | -83 | -186 | -5 | 0 | -105 |
| Financing Cash Flow | $-83 | $13,095 | $12,602 | $12,099 | $-105 |
| Beginning Cash Position | 12,584 | 9,906 | 9,906 | 9,906 | 9,906 |
| End Cash Position | 9,955 | 12,584 | 15,593 | 18,284 | 9,573 |
| Net Cash Flow | $-2,628 | $2,677 | $5,686 | $8,377 | $-334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,545 | -10,326 | -6,846 | -3,710 | -222 |
| Capital Expenditure | -1 | -92 | -70 | -12 | -6 |
| Free Cash Flow | -2,546 | -10,418 | -6,916 | -3,722 | -229 |